plasma samples ( containing 20 mmol/l benzamidine to prevent complex formation ex vivo ) from patients undergoing systemic urokinase therapy ( 1 x 10 ( 6 ) iu/60 min intravenously [ iv ] ) after myocardial infarction were also studied .
C0042071
urokinase
C0027051
myocardial infarction